Cabio Biotech (Wuhan) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	153.15	239.68	494.33	664.47
Trading Asset Securities	-	0.03	0.03	32.8	11.5
Cash & Short-Term Investments	258.22	153.18	239.71	527.13	675.97
Cash Growth	68.57%	-36.10%	-54.53%	-22.02%	-21.48%
Accounts Receivable	-	285.41	265.64	216.43	178.29
Other Receivables	-	36.39	31.01	40.56	41.08
Receivables	-	321.81	296.65	256.99	219.37
Inventory	-	139.32	112.58	81.49	74.86
Other Current Assets	-	42.36	59.84	41.76	24.66
Total Current Assets	-	656.67	708.78	907.37	994.85
Property, Plant & Equipment	-	767.92	643.28	485.96	241.93
Long-Term Investments	-	191.84	175.37	150.22	117.31
Other Intangible Assets	-	43.09	41.08	36.34	13.15
Long-Term Deferred Tax Assets	-	9.36	11.13	11.49	5.98
Long-Term Deferred Charges	-	1.86	3.67	2.45	0.38
Other Long-Term Assets	-	16.07	28.18	17.52	74.89
Total Assets	-	1,687	1,611	1,611	1,448
Accounts Payable	-	62.07	70.86	107.34	31.43
Accrued Expenses	-	21.97	15.32	19.15	18.05
Short-Term Debt	-	6.01	11.01	30.03	-
Current Portion of Leases	-	0.64	1.09	1.35	0.84
Current Income Taxes Payable	-	5.18	5.86	16.02	5.22
Current Unearned Revenue	-	0.76	2.08	0.43	0.23
Other Current Liabilities	-	5.17	6.2	6.12	4.18
Total Current Liabilities	-	101.79	112.42	180.44	59.95
Long-Term Debt	-	12.63	-	-	-
Long-Term Leases	-	0.02	0.66	1.66	1.58
Long-Term Unearned Revenue	-	2.73	4.2	3.66	4.92
Long-Term Deferred Tax Liabilities	-	0.11	0.31	0.54	0.22
Total Liabilities	-	117.27	117.6	186.31	66.68
Common Stock	-	168.31	168.31	120	120
Additional Paid-In Capital	-	811.83	811.83	858.02	844.82
Retained Earnings	-	587.5	496.95	441.64	416.9
Treasury Stock	-	-10.82	-	-	-
Comprehensive Income & Other	-	-0.74	-0.74	-0.73	-0.69
Total Common Equity	1,628	1,556	1,476	1,419	1,381
Minority Interest	-	13.46	17.54	6.1	0.79
Shareholders' Equity	1,639	1,570	1,494	1,425	1,382
Total Liabilities & Equity	-	1,687	1,611	1,611	1,448
Total Debt	104.66	19.29	12.76	33.05	2.42
Net Cash (Debt)	153.56	133.89	226.95	494.08	673.55
Net Cash Growth	14.70%	-41.01%	-54.07%	-26.65%	-21.76%
Net Cash Per Share	0.92	0.80	1.34	2.92	4.00
Filing Date Shares Outstanding	162.86	167.75	168.31	168	168
Total Common Shares Outstanding	166.8	167.75	168.31	168	168
Working Capital	-	554.88	596.35	726.92	934.9
Book Value Per Share	9.76	9.28	8.77	8.45	8.22
Tangible Book Value	1,586	1,513	1,435	1,383	1,368
Tangible Book Value Per Share	9.51	9.02	8.53	8.23	8.14
Buildings	-	241.94	241.02	191	94.66
Machinery	-	636	594.21	529.66	312.24
Construction In Progress	-	265.55	133.05	49.59	104.18

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.